Quest Plans $1.2B Note Offering, $250M Tender Offer
By Zachary Zagger ( March 5, 2015, 4:45 PM EST) -- Quest Diagnostics Inc. said Thursday it plans to refinance its debt through a $1.2 billion offering of senior notes and a tender offer for $250 million in existing notes a month after settling patent infringement litigation with Myriad Genetics Inc. over BRCA cancer gene testing....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.